Citations

Showing 10 of 108104 citations.

Behavioral parenting skills as a novel target for improving medication adherence in young children: Feasibility and acceptability of the CareMeds intervention
Bouchard, Elizabeth , Patel, Hital, Vincent, Paula C., LaValley, Susan, Devonish, Julia A. , Wadium, Jessica, Kelly, Kara M. , Epstein, Leonard H. , Wen, Xiaozhong

Mayo Clinic

Pediatric Hematology and Oncology | February 10, 2022 | Volume: 39 | Issue: 6 | Pages: 529-539

10.1080/08880018.2022.2025964 | PMID 35139726 Get It

Resolving the Heterogeneous Tumor-Centric Cellular Neighborhood through Multiplexed, Spatial Paracrine Interactions in the Setting of Immune Checkpoint Blockade
Maus, Rachel L.G., Leontovich, Alexey A. , Moore, Raymond M. , Becher, Laura , Nevala, Wendy K. , Flotte, Thomas J. , Guo, Ruifeng , Dicke, Betty A., Yan, Yiyi , Leontovich, Alexey L, Schimke, Jill, Guo, Ruifeng , Schimke, Jill M. , Markovic, Svetomir N.

Mayo Clinic

Cancer Research Communications | February 10, 2022 | Volume: 2 | Issue: 2 | Pages: 78-89

10.1158/2767-9764.crc-21-0146 | PMID 35992329 Get It

Direct interactions between tumor and immune cells mediate the antitumor effect of all modern cancer immunotherapeutic agents. Simultaneously, tumor cells have evolved mechanisms of evasion, including the downregulation of HLA-I, potentially disrupting the mechanism of action employed by many immune checkpoint inhibitors. And yet, the in situ interplay between these cells within the tumor immune microenvironment (TIME) remains elusive. Recent advances in histologic multiplex bioimaging platforms have enabled in-depth molecular characterization of single cells within spatially preserved and clinically archived tumor tissues. Herein, we applied multiplex immunofluorescence to excisional lymph node biopsies from 14 patients with metastatic melanoma who experienced clear objective responses to immunotherapy (7 complete response; 7 progressive disease) to determine distinguishing features of the TIME in the pretreatment setting. Distinct regions of the TIME were evaluated using 35 proteins probing tumor, immune, and vasculature components across 323 fields of view. Single-cell compositional analysis confirmed established prognostic immune cell types including increased prevalence of cytotoxic T cells within the tumor core fields of view of responders. Integrating single-cell quantification with the spatial arrangement of cellular neighborhoods surrounding tumor cells revealed novel, spatial immune signatures capable of stratifying TIME based on clinical response. Our analysis revealed dynamic cellular composition of the tumor-centric cellular neighborhood (TCCN) based on anatomic subregion, functional expression of HLA-I by the index tumor cell and ultimately clinical response to immunotherapy. Overall, this study provides an analytic framework to resolve the cellular complexity of the TIME, increasingly relevant to the outcomes of modern cancer immunotherapy. Significance: Findings from this work propose a novel approach to resolving clinical heterogeneity of the TIME by objectively quantifying the cellular interactions occurring in metastatic melanoma lymph node tissue utilizing multiplex immunofluorescence. This study provides an analytic and biologically derived unit of measure, the TCCN which is customizable for studying critical paracrine interactions within spatially preserved tissue of various cancers and across the spectrum of multiplex imaging modalities.
Acute cerebrovascular events in severe and nonsevere COVID-19 patients: a systematic review and meta-analysis
Quintanilla‐Sánchez, Carolina , Salcido‐Montenegro, Alejandro , González‐González, José Gerardo , Rodríguez‐Gutiérrez, René , González-González, José Gerardo

Mayo Clinic

Reviews in the Neurosciences | February 10, 2022 | Volume: 33 | Issue: 6 | Pages: 631-639

10.1515/revneuro-2021-0130 | PMID 35142148 Get It

Abstract The degree to which COVID-19 severity influences the development of acute cerebrovascular events (ACVE) is unknown. Therefore, we aimed to describe the prevalence and risk of ACVE in patients with severe and nonsevere COVID-19. We systematically reviewed MEDLINE, EMBASE, Web of Science, and Scopus and identified observational and interventional studies of patients with COVID-19 allocated by respiratory severity that reported ACVE development. Case reports/series were excluded. The main outcome assessed was the pooled rate of ACVE in patients with severe and nonsevere COVID-19. To determine the risk of ACVE development by COVID-19 severity, a meta-analysis was performed. PROSPERO registration number: CRD42020178905. About 19 of 5758 identified studies were analyzed. From 11,886 COVID-19 patients analyzed, 421 had at least one ACVE [3.6%, 95% confidence interval (CI) 2.904–4.179]. Severe COVID-19 increased the risk of ACVE (odds ratio 1.96, 95% CI 1.22–3.15; P = 0.005; I 2 = 64%), specifically hemorrhagic stroke (4.12, 2.0–8.53; P = 0.001; I 2 = 0%). There was no difference in the risk of developing ischemic stroke between patients with severe and nonsevere COVID-19 (1.53, 0.87–2.7; P = 0.14; I 2 = 52%). From the patients who developed any ACVE, those with severe COVID-19 had a greater mortality risk than those with nonsevere COVID-19 (3.85, 1.08–13.70; P = 0.04; I 2 = 0%). The main limitations of our study were the heterogeneity found in the main meta-analysis studies and in their reported definition for COVID-19 severity. In conclusion, our findings provide evidence that COVID-19 respiratory severity could lead to ACVE development that increases mortality. The effect of COVID-19 management in ACVE needs to be evaluated.
Research priorities in liver transplant anesthesiology: Results of a survey of liver transplant anesthesiologists
Smith, Natalie , Zerillo, Jeron , Lin, Hung‐Mo, Ouyang, Yuxia , Chadha, Ryan , DeMaria, Samuel

Mayo Clinic

Clinical Transplantation | February 10, 2022 | Volume: 36 | Issue: 5 | Pages: No page available

10.1111/ctr.14607 | PMID 35141959 Get It

AbstractOptimal perioperative care contributes to improved patient outcomes, as demonstrated in the field of liver transplant (LT). The evolution in perioperative care over the past two decades has been driven by research in areas such as preoperative testing, coagulation management, and intraoperative monitoring. However, much of this research is driven by local institutional pressures and practices with a dearth of studies emanating from research consortia or other groups of experts within the field. To better characterize the top research questions in the field, we queried a group of 128 LT anesthesiologists representing 87 international liver transplant centers with a response from 71 practitioners (59.2%). Three experts then codified the responses into the top 20 questions, which were sent to the survey recipients as a second survey to rank order. Seventy‐five respondents (61.5%) provided responses, which were merged into a weighted ranked priority list and analyzed by respondent location and center size. The highest ranked question was, “What intraoperative anesthetic management/interventions affect graft outcome?” Most of the top research questions focused on preoperative risk factor management or optimization and intraoperative management techniques. In general, this priorities list may serve as a guide for transplant anesthesiology researchers to focus future research endeavors on shared interests that improve patient care.
Vasculitis in the setting of COVID ‐19: From the disease to the vaccine. Report of a case of cutaneous vasculitis after immunization
Criado, Paulo Ricardo , Giordani, Lucas Prezotto, Yoshimoto, Thais Akemi , Vieira, Ingrid Campos, Landman, Gilles , Pincelli, Thaís , Pincelli, Thais Prota, Pincelli, T , Criado, P R

Mayo Clinic

Dermatologic Therapy | February 10, 2022 | Volume: 35 | Issue: 5 | Pages: No page available

10.1111/dth.15367 | PMID 35141989 Get It

Laryngeal Actinomycosis Presenting as Foreign Body
Walker, Brian A. , Gerber, Mark E.

Mayo Clinic

OTO Open | February 10, 2022 | Volume: 6 | Issue: 1 | Pages: No page available

10.1177/2473974x211073701 | PMID 35174301 Get It

A multidisciplinary approach to the development of digital twin models of critical care delivery in intensive care units
Zhong, Xiang , Sarijaloo, Farnaz Babaie , Prakash, Aditya Mahadev , Park, Jaeyoung , Huang, Chanyan , Barwise, Amelia , Herasevich, Vitaly , Gajic, Ognjen , Pickering, Brian W. , Dong, Yue , Barwise, Amelia K , Gajic, Ognjen , Herasevich, Vitaly , Dong, Yue

Mayo Clinic

International Journal of Production Research | February 10, 2022 | Volume: 60 | Issue: 13 | Pages: 4197-4213

10.1080/00207543.2021.2022235 Get It

Endurance and gait speed relationships with mild cognitive impairment and dementia
Windham, B. Gwen , Parker, Sara B., Zhu, Xiaoqian , Gabriel, Kelley Pettee , Palta, Priya, Sullivan, Kevin , Parker, Kirby G., Griswold, Michael , Windham, Beverly Gwen , Sullivan, Kevin J , Knopman, David S. , Gottesman, Rebecca F. , Mosley, Thomas H.

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | February 10, 2022 | Volume: 14 | Issue: 1 | Pages: No page available

10.1002/dad2.12281 | PMID 35155735 Get It

AbstractIntroductionSlower mobility is associated with mild cognitive impairment (MCI) and dementia. We examined the interaction of endurance with gait speed on prevalent MCI and dementia.MethodsCross‐sectional multinomial regression in the ARIC cohort (n = 2844 participants; 71 to 94 years; 44% men; 18% Black persons) with cognitive status (normal/MCI/dementia), 4 m gait speed, and endurance (2 minute walk [2MW]).ResultsFaster gait speed (up to but not above 1 m/s) and better 2MW were separately associated with lower dementia risk. Good performance in both (2MW = 200 m, gait speed = 1.2 m/s) was associated with 99% lower dementia (Relative Prevalence Ratio [RPR] = 0.01 [95% CI: 0.0 to 0.06]) and 73% lower MCI, RPR = 0.27 (0.15 to 0.48) compared to poor performance in both (2MW = 100 m, gait speed = 0.8 m/s). Models incorporating a gait speed‐by‐2MW interaction term outperformed gait speed‐only models (P < .001).DiscussionGait speed relationships with dementia diminish at faster gait speeds. Combining endurance with gait speed may yield more sensitive markers of MCI and dementia than gait speed alone.
Association between CSF biomarkers of Alzheimer's disease and neuropsychiatric symptoms: Mayo Clinic Study of Aging
Krell‐Roesch, Janina , Rakuša, Martin , Syrjanen, Jeremy A. , Harten, Argonde C. van , Lowe, Val J. , Jack, Clifford R. , Kremers, Walter K. , Petersen, Ronald C. , Vassilaki, Maria , Geda, Yonas E. , Geda, Yonas E , Jack, Clifford R , Kremers, Walter K , Knopman, David S. , Stokin, Gorazd B.

Mayo Clinic

Alzheimer's & Dementia | February 10, 2022 | Volume: 19 | Issue: 10 | Pages: 4498-4506

10.1002/alz.12557 | PMID 35142047 Get It

Abstract Introduction We examined the association between cerebrospinal fluid (CSF)‐derived biomarkers of Alzheimer's disease and neuropsychiatric symptoms (NPS) in older non‐demented adults. Methods We included 784 persons (699 cognitively unimpaired, 85 with mild cognitive impairment) aged ≥ 50 years who underwent CSF amyloid beta (Aβ42), hyperphosphorylated tau 181 (p‐tau), and total tau (t‐tau) as well as NPS assessment using Beck Depression and Anxiety Inventories (BDI‐II, BAI), and Neuropsychiatric Inventory Questionnaire (NPI‐Q). Results Lower CSF Aβ42, and higher t‐tau/Aβ42 and p‐tau/Aβ42 ratios were associated with BDI‐II and BAI total scores, clinical depression (BDI‐II ≥ 13), and clinical anxiety (BAI ≥ 10), as well as NPI‐Q–assessed anxiety, apathy, and nighttime behavior. Discussion CSF Aβ42, t‐tau/Aβ42, and p‐tau/Aβ42 ratios were associated with NPS in community‐dwelling individuals free of dementia. If confirmed by a longitudinal cohort study, the findings have clinical relevance of taking into account the NPS status of individuals with abnormal CSF biomarkers.
Slowing gait speed precedes cognitive decline by several years
Blennow, Kaj , Skoog, Johan , Guo, Xinxin , Sacuiu, Simona , Zettergren, Anna , Kern, Silke , Skillbäck, Tobias Borgh , Zetterberg, Henrik , Rydén, Lina , Wetterberg, Hanna , Mielke, Michelle M. , Skoog, Ingmar

Mayo Clinic

Alzheimer's & Dementia | February 10, 2022 | Volume: 18 | Issue: 9 | Pages: 1667-1676

10.1002/alz.12537 | PMID 35142034 Get It

Abstract Introduction In this longitudinal study, we aimed to examine if slowing gait speed preceded cognitive decline and correlated with brain amyloidosis. Methods The sample (n = 287) was derived from the Gothenburg H70 Birth Cohort Studies, with follow‐ups between 2000 and 2015. Gait speed was measured by indoor walk, and cognition using the Clinical Dementia Rating (CDR) score. All participants had CDR = 0 at baseline. Some participants had data on cerebrospinal fluid (CSF) amyloid beta (Aβ) 1‐42 concentrations at the 2009 examination. Results Gait speed for participants who worsened in CDR score during follow‐up was slower at most examinations. Baseline gait speed could significantly predict CDR change from baseline to follow‐up. Subjects with pathological CSF Aβ 1‐ 42 concentrations at the 2009 visit had lost more gait speed compared to previous examinations. Discussion Our results indicate that gait speed decline precedes cognitive decline, is linked to Alzheimer's pathology, and might be used for early detection of increased risk for dementia development.